CORCEPT THERAPEUTICS INC short interest in 2025
In 2025, CORCEPT THERAPEUTICS INC's disclosed short interest ran from 15.52% of shares outstanding on 15 Jan 2025 to 8.70% on 31 Dec 2025, a change of -6.82 percentage points. The year's high was 15.77% on 31 Mar 2025 and its low 8.70% on 31 Dec 2025, averaging 11.77% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 22.14 days on 15 Jan 2025. Full history: CORCEPT THERAPEUTICS INC.
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2025 in figures
- Start of year
- 15.52% (15 Jan 2025)
- End of year
- 8.70% (31 Dec 2025)
- Change
- -6.82 pp
- High
- 15.77% (31 Mar 2025)
- Low
- 8.70% (31 Dec 2025)
- Average
- 11.77%
- Highest days to cover
- 22.14 (15 Jan 2025)
- SEC filings marked
- 8
Every report in 2025
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2025 | 15.52% | 22.14 | |
| 31 Jan 2025 | 15.09% | 15.90 | |
| 14 Feb 2025 | 14.69% | 19.75 | |
| 28 Feb 2025 | 15.31% | 12.28 | 10-K filed, results (8-K) |
| 14 Mar 2025 | 15.59% | 12.61 | |
| 31 Mar 2025 | 15.77% | 8.01 | |
| 15 Apr 2025 | 11.73% | 5.11 | |
| 30 Apr 2025 | 12.43% | 9.52 | |
| 15 May 2025 | 11.77% | 9.54 | 10-Q filed, results (8-K) |
| 30 May 2025 | 11.92% | 11.89 | |
| 13 Jun 2025 | 11.93% | 7.36 | |
| 30 Jun 2025 | 10.79% | 5.60 | |
| 15 Jul 2025 | 10.58% | 10.70 | |
| 31 Jul 2025 | 10.48% | 14.40 | 10-Q filed, results (8-K) |
| 15 Aug 2025 | 10.05% | 11.88 | |
| 29 Aug 2025 | 10.33% | 17.49 | |
| 15 Sep 2025 | 10.25% | 15.77 | |
| 30 Sep 2025 | 10.10% | 9.97 | |
| 15 Oct 2025 | 9.72% | 9.77 | |
| 31 Oct 2025 | 10.50% | 14.19 | |
| 14 Nov 2025 | 9.67% | 13.92 | 10-Q filed, results (8-K) |
| 28 Nov 2025 | 9.83% | 19.78 | |
| 15 Dec 2025 | 9.61% | 11.55 | |
| 31 Dec 2025 | 8.70% | 3.04 |
See also: CORCEPT THERAPEUTICS INC's full history · most shorted US stocks of 2025 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.